Good Neighbor Pharmacy franchise: cost, earnings and risks
2025 FDD, with page numbersSBA 7(a) data through FY2026Updated Current filing
Good Neighbor Pharmacy in brief
Good Neighbor Pharmacy is a franchise network of independently owned community pharmacies backed by distributor Cencora. It has 2,204 units, all franchised (Item 20). Opening one costs $279K – $575K under the 2025 FDD; Item 19 sales: partial, no system average. Our Verdict grade for Good Neighbor Pharmacy is B (65/100, Second tier), an editorial assessment, not investment advice: 264 units left in 2024.
Quick verdict
Compared with the median of 117 Healthcare brands.
p. 28
2025 FDD, Item 7, page 28GNP Premier Fee – 3 months $1,797 As arranged As agreed ABDC Total(l): $278,797 to $575,205 Explanatory Notes to Charts A and B. …Quoted from the franchisor's filing; the figure on this page is rounded. Table text, cells in reading order; column headings may sit outside the quoted lines.Read page 28 free in a state registry's public copy of the filing.Get the FDD PDF · $9
Neutral - range spans the median
Better - Below the median: costs less
p. 26
2025 FDD, Item 7, page 26Read page 26 free in a state registry's public copy of the filing.Get the FDD PDF · $9Worse - Above the median: more cash needed
p. 55
2025 FDD, Item 20, page 55TABLE NO. 1 VOLUNTARY PHARMACIES SYSTEMWIDE OUTLET SUMMARY FOR FISCAL YEARS 2023 TO 2025 ... Licensed 2023 240 199 -41 11 2515 2497 -18 2024 199 182 -17 0 2497 2476 -21 2025 182 157 -25 0 2476 2,361 …Quoted from the franchisor's filing. Table text, cells in reading order; column headings may sit outside the quoted lines.Read page 55 free in a state registry's public copy of the filing.Get the FDD PDF · $9
Better - Above the median: larger system
Review - median 0.0%: read the Item 20 exits
Item 12
2025 FDD, Item 12Read Item 12 free in a state registry's public copy of the filing (where).Get the FDD PDF · $9Worse - no protection
p. 44
2025 FDD, Item 15, page 44Read page 44 free in a state registry's public copy of the filing.Get the FDD PDF · $9Neutral - no benchmark
p. 17
2025 FDD, Item 3, page 17Read page 17 free in a state registry's public copy of the filing.Get the FDD PDF · $9Review - some history
✓Better than median✕WorseWithin 10% or no benchmark!Read the details
Better or worse means more than 10% from the median. Blue links open the source page. Editorial assessment, not investment advice. Method
The $19 report: every fee, the 264 units that left in 2024 and attorney questions by Item, as a PDF. One-time; full refund within 7 days if the data does not match the FDD.
Compare:Prime IV Hydration & Wellnessgrade A986 Pharmacygrade AThe Joint Chiropracticgrade A
Quick facts, each with its FDD Item and page
- Category
- Healthcare
- Franchisor (legal entity)
- AmerisourceBergen Drug Corporation, organized in Delawarep. 8
- Parent company
- Cencora, Inc.p. 8
- Headquarters
- Pennsylvaniap. 8
- Franchising since
- 2009p. 8
- CEO
- Robert P. Mauchp. 16
- States and territories listed
- 51 (registered or offered in, not where units may open)
FranchiseVerdict grade
65/100
Second tier
65 this brand51 Healthcare medianlikely 59–71: narrower with more SBA loans (high confidence)
Higher is better · an editorial assessment, not investment advice
#768 of 3,066 graded brands
- Helps: Financial health: Audited financials
- Helps: Scale: 2,204 franchised units, 2,361 in all
- Weighs on it: Unit growth: -94 franchised outlets over the two years to 2024
2025 FDDGraded on the 2025 filing.
What does a Good Neighbor Pharmacy franchise cost?
$279K – $575K to open
The Item 7 startup range. No single royalty and ad fund percentages to total, so no yearly fee figure.
p. 28
2025 FDD, Item 7, page 28GNP Premier Fee – 3 months $1,797 As arranged As agreed ABDC Total(l): $278,797 to $575,205 Explanatory Notes to Charts A and B. …Quoted from the franchisor's filing; the figure on this page is rounded. Table text, cells in reading order; column headings may sit outside the quoted lines.Read page 28 free in a state registry's public copy of the filing.Get the FDD PDF · $9
Cost breakdown
p. 40
2025 FDD, page 40Read page 40 free in a state registry's public copy of the filing.Get the FDD PDF · $9Source: FDD 2025 · Items 5–7 (fees and startup costs)
Do you qualify? The filing states no minimum net worth or liquid capital; check the franchisor's site for its own requirements. Ask AmerisourceBergen Drug Corporation (Item 1: 1 West First Avenue, Conshohocken, PA 19428) and your lender what they require, and keep living costs for the first year outside the deal.
Full Item 7 breakdown15 line items
Initial investment breakdown
| Line item | Low | High | |
|---|---|---|---|
| Real Property Lease/Leasehold Improvements | $50K | $110K | |
| Leasehold Improvement Management Services | $0 | $1.5K | |
| Furniture, Fixtures, and Equipment | $25K | $75K | |
| Pharmacy Management System Hardware and Software | $0 | $15K | |
| Point of Sale System Hardware and Software | $0 | $35K | |
| Interior Signage | $0 | $5K | |
| Exterior Signage | $0 | $20K | |
| Fees for Optional Goods and Services (3 months) | $0 | $1.91K | |
| Insurance | $1.5K | $5K | |
| Opening Inventory (exclusive of GNP Private Label Products) | $75K | $125K | |
| GNP Private Label Products | $5K | $12K | |
| Pharmacy and Business Licenses | $500 | $3K | |
| Additional Advertising and Marketing | $0 | $15K | |
| Additional Funds - 3 months | $120K | $150K | |
| GNP Premier Fee - 3 months | $1.8K | $1.8K | |
| Total initial investment | $279K | $575K |
When each item is due
- Real Property Lease/Leasehold Improvements
- As agreed
- Leasehold Improvement Management Services
- As agreed
- Furniture, Fixtures, and Equipment
- As agreed
- Pharmacy Management System Hardware and Software
- As agreed
- Point of Sale System Hardware and Software
- As agreed
- Interior Signage
- As agreed
- Exterior Signage
- As agreed
- Fees for Optional Goods and Services (3 months)
- As agreed
- Insurance
- As agreed
- Opening Inventory (exclusive of GNP Private Label Products)
- Net 10 days after semi-monthly billing
- GNP Private Label Products
- As agreed
- Pharmacy and Business Licenses
- As agreed
- Additional Advertising and Marketing
- As agreed
- Additional Funds - 3 months
- As agreed
- GNP Premier Fee - 3 months
- As agreed
Line items extracted from FDD Item 7. Ranges reflect the franchisor's stated low and high per line. The total row is the total as printed in Item 7. Actual costs may fall outside this range depending on market and build-out scope.
Item 6 · what you pay once you are open
Ongoing fees
| Fee | Amount |
|---|---|
| Royalty (flat) | $599/month GNP Premier Fee; may increase upon 120 days notice |
| Marketing / ad fund | 0.0% |
| Technology feesNo separate technology fee; pharmacy management system and POS system costs are in Item 7 | See the list |
How much do Good Neighbor Pharmacy units make?
Partial, no system average
What Item 19 of the filing says instead of a sales figure.
Groups, ranges and the one-unit box
Source: FDD 2025 · Item 19 (sales and earnings)
Items 6 (other fees), 7 (startup costs) and 19 (sales and earnings) · assumptions labeled
What you could make and lose: one unit
What one Good Neighbor Pharmacy unit would ask of you, from the filing's Item 7 total and labeled assumptions.
How these figures are worked out
- Loan (assumption): 80% of the $427K Item 7 midpoint is a $342K loan, paid over 10 years at 10.5%: $55K a year. SBA 7(a)-style terms on a long-term rate; your lender sets yours. Good Neighbor Pharmacy's past SBA 7(a) loans averaged 7.6% at approval; 7(a) rates move with the prime rate, so 10.5% is a current-rate assumption, not this brand's history.
What you put at risk
Your own cash in: about $85K Assumption (the part the loan does not cover of the $427K Item 7 midpoint), plus whatever anything Item 7 leaves out (its notes say what). The loan is $342K.
Personal guarantee. SBA 7(a) loans require a personal guarantee from anyone who owns 20% or more of the business. If the unit cannot pay, the lender can collect from you personally, which can include your savings and your home. The worst case is losing the cash you put in and still owing the rest of the loan.
Gross sales are not profit, and none of these figures is take-home pay until tax and every operating cost are paid. The assumptions are ours, not the filing's. Not investment advice.
Returns model: one unit, several units, buying an existing unit (editable, pre-filled from this filing).
Item 19 · Source: 2025 FDD · filed by AmerisourceBergen Drug Corporation
Financial performance
Percentile ranks within Healthcare
Each rank is among the Healthcare brands that report that figure (the count is under each bar).
Good Neighbor Pharmacy SBA loans and unit growth
174 in · 264 out
-94 franchised outlets over the two years to 2024 (2,298 to 2,204, -4.1% in total, -2.1% a year compounded). Lenders, states and loans by approval year inside; the charge-off rate is the Quick verdict tile.
States and SBA detail
Source: FDD 2025 · Item 20 (outlets opened, closed and transferred)
Item 20 (outlet counts) · unit dynamics
The growth chart
- Company-owned
- 0
- Corporate units in the system
- % franchised
- 100%
- vs corporate-owned
Last fiscal year · Item 20 rates and pipeline
- Reacquired
- 0
- Franchisor bought back
- Signed, not yet open
- 0
- Item 20 Table 5
- Projected new
- 230
- Franchisor's next-year forecast
Item 20 · franchised units at year end
Franchised units fell from 2,298 in 2022 to 2,204 in 2024
Axis does not start at zero.
Source and method
Item 20 (outlet counts) outlets · 16 states
Where current outlets are
States with at least one current outlet in the Item 20 list the franchisor prints. Former owners are not counted, and this is not a list of where the franchisor may sell new units.
Current outlets · 16 statesNo current outlet
122 current outlets in 16 states: the 122 on the owner list, of 2,204 franchised at year end (Item 20). 19 former owners (terminated, transferred, not renewed or otherwise left) listed separately.
Counts only, from the list the franchisor prints in Item 20. The contact details are for your own due diligence and are not shown here.
Government records
SBA loan data
Matched to this brand from SBA 7(a) and 504 FOIA loan records.
- Loans on file
- 11
- SBA 7(a) loans matched to this brand, incl. those still being repaid
- Loan volume
- $23.1M
- Average loan
- $2.1M
- loan volume divided by loans
- Charge-off rate
- 2 resolved of 11 loans: too few to judge
- Limited SBA coverage: 11 loans, rate hidden until 10 have resolved and loans reach 2% of franchised units
- Paid in full
- 2 resolved of 11 loans: too few to judge
- Charge-off, loans approved FY2019–FY2021
- 2 resolved of 11 loans: too few to judge
- Average interest rate
- 7.6%
- Jobs reported
- 262
- Lender concentration
- 45%
- top lender's share
Cumulative: every 7(a) loan matched to this brand in the SBA’s FOIA files, approved FY1992 onward. Historical lending data, not predictive of future performance. How SBA charge-off rates are calculated
Borrower mix: of the 11 loans with a recorded business age, 0 (0%) went to startups or businesses under two years old and 11 (100%) to established businesses or ownership changes.
All 5 SBA lenders, by loan count
| Loans | Volume | Charge-off |
|---|---|---|
| First Financial Bank | ||
| 5 | $13.9M | Too few1 resolved |
| Live Oak Banking Company | ||
| 3 | $5.7M | Too few1 resolved |
| First Bank of the Lake | ||
| 1 | $150K | Too few0 resolved |
| American Momentum Bank | ||
| 1 | $1.9M | Too few0 resolved |
| Mission Valley Bank | ||
| 1 | $1.4M | Too few0 resolved |
A lender’s rate counts only its resolved loans, the loans that have finished (paid in full or charged off); a 0.0% often means few of its loans have finished. Under 10 resolved loans, the rate reads “Too few”.
Loans by state and charge-offs by approval year on the Good Neighbor Pharmacy SBA loan report.
Explore lender portfolios on Bank Reports or regional data on State Reports.
Good Neighbor Pharmacy lawsuits and risks
PA + OH + 1 more government actions
Matter with no printed caption (pending, filed 2022). 4 checks to read inside.
p. 20
2025 FDD, Item 3, page 20On December 29, 2022, the Department of Justice filed a civil complaint (the “Complaint”) against Cencora, ABDC, and Integrated Commercialization Services, LLC (“ICS”), a subsidiary of Cencora, alleging violations of the Controlled Substances Act. Specifically, the Complaint alleQuoted from the franchisor's filing.Read page 20 free in a state registry's public copy of the filing.Get the FDD PDF · $9
Cases and checks
Things to check before you sign (4)
- Net -90 franchised outlets in 2024 (Item 20, outlet counts). Ask owners why outlets closed.
- 2 pending matters name the franchisor in Item 3 (litigation). Pending claims are allegations, not findings; for a system this size the score counts the legal record in the brand's favour. Read the matter in Item 3.
- The franchisor keeps the right to compete inside your territory (Item 12, territory).
- You waive a jury trial in disputes with the franchisor (Item 17, renewal, termination and disputes).
Checked and clear: no auditor doubt that the franchisor can keep operating, no rule that the owner must run it personally and the full filing on file, and an Item 19 average from 1,740 units. Not on file here, so ask: SBA charge-off rate against the category median and supplier rebates.
Source: SBA 7(a) FOIA · FDD Items 3, 21
Verdict grade + FDD Items 3 (litigation), 4 (bankruptcy), 8 (required suppliers), 16 (what you may sell), 21 (audited financials)
Risk and legal
Grade B: Second tier, 65/100 (category median 51); the full grade is at the top of the page.
How the grade is built
Litigation (Item 3)
Subject: the franchisor is a named party (defendant).
Three disclosed matters: (1) Mullen/Omni/Sypula False Claims Act settlement ($625M); (2) National Prescription Opiate MDL litigation (various settlements including $4.3B Distributor Settlement Agreement); (3) DOJ civil complaint against Cencora/ABDC for Controlled Substances Act violations re suspicious order reporting.
Bankruptcy (Item 4)
None disclosed
Audited financials (Item 21)
Yes · Ernst & Young LLP
Item 21 revenue, parent or group statements
The revenue figures are in the Franchisor tab, under The franchisor.
Franchisor entity revenue (not unit-level)
Audited consolidated financial statements are those of the franchisor's parent, Cencora, Inc. (formerly AmerisourceBergen Corporation), for fiscal year ended September 30, 2025; figures originally reported in thousands. Franchisor is AmerisourceBergen Drug Corporation.
ⓘ These are the parent company's consolidated financials (the parent guarantees the franchisor), not this brand's standalone results; the figure reflects the whole corporate group, not this brand alone.
Supplier relationship · Items 8 & 16
Ask what the franchisor earns on the supplies it sells you or the rebates it takes (Item 8).
- Franchisor sells you products: Yes
- Must buy proprietary products: Yes
- Restricted to system-approved products: No
Notes from the filing review · not the score inputs
- 01HIGHExtensive litigation history including False Claims Act settlements, opioid distribution MDL settlements, public nuisance verdict, and DOJ Controlled Substances Act violations creates significant legal and operational risk
- 02MINORNo average gross sales or net income disclosure (Item 19) prevents prospective franchisees from assessing realistic earning potential and ROI
- 03MINORUnprotected territory with $599 monthly royalty creates competitive vulnerability; franchisor can saturate your market without compensation
- 04MEDZero franchise fee indicates potential financial weakness of franchisor and limited resources for franchisee support and system development
Severity inferred from the FDD text · not a regulatory classification
Good Neighbor Pharmacy franchise agreement terms
5 years
Initial term (Item 17); renewal, territory, training and suppliers inside.
All contract terms
Source: FDD 2025 · Items 11, 12, 17
FDD Items 12 (territory), 15 (owner participation) and 17 (renewal, termination and disputes)
Contract and territory detail
| Protected territory | No |
|---|---|
| Exclusive territory | No |
| Online sales rights | Allowed |
| Franchisor can compete | Yes |
| Who runs it (Item 15) | A manager may run it |
| Right of first refusal | No |
| Transfer requires consent | Yes |
| Termination notice | 60 days |
| Mandatory arbitration | No |
| Arbitration location | Conshohocken, PA (ABDC corporate headquarters) - mediation at ABDC option |
| Jury trial waiver | Yes |
| Governing law | PA |
Items 10 (financing), 11 (training and support)
Training and operations
- Classroom training
- 0 hrs
- On-the-job training
- 0 hrs
- Training location
- None; no initial training currently offered
- Ongoing training
- Optional
- Site selection
- Franchisee
- Franchisor financing
- Not offered
- Item 10
Items 5 (initial fees) & 11 (training and support)
Franchisor support
Good Neighbor Pharmacy pros and cons
4 pros · 1 con
Helped by financial health, scale, legal record and transparency. Held back by unit growth.
Pros, cons and peers
Why a B, factor by factor
- Financial health HelpsAudited financials; no going-concern doubt; statements are the parent's, so this stays near neutral
- Unit economics NeutralNo Item 19 sales figure to set against the investment, so neutral
- Unit growth Weighs on it, weakest dimension-94 franchised outlets over the two years to 2024 (2,298 to 2,204, -4.1% in total, -2.1% a year compounded); turnover 12.0%
- Scale Helps2,204 franchised units, 2,361 in all; franchising since 2009
- Legal Helps3 matters naming the franchisor among the Item 3 matters we list (0.1 per 100 outlets)
- Transparency HelpsItem 19 discloses financial performance; audited financials
From the six scored dimensions, an editorial assessment, not investment advice. How the score is built
Who are you contracting with?
AmerisourceBergen Drug Corporation, owned by Cencora, Inc.
Item 1 (the franchisor) · who you're contracting with
The franchisor
Corporate structure & franchisor financials
- Legal entity
- AmerisourceBergen Drug Corporation
- Parent company
- Cencora, Inc.
- p. 8
- Predecessor
- Bergen Brunswig Drug Company
- Prior franchisor entity
- CEO title
- President and Chief Executive Officer
- Robert P. Mauch
- Incorporated in
- DE
- HQ
- 1 West First Avenue, Conshohocken, PA 19428
- Auditor
- Ernst & Young LLP
- Audited financials
- Item 21 revenue, parent or group statements
- $321.3B
- latest fiscal year in the 2025 FDD; $294.0B the year before
| Brand | Investment (Item 7) | Item 19 average | Units (Item 20) |
|---|---|---|---|
| Prime IV Hydration & Wellness(A) | $191K – $632K | $567K | 154 |
| 986 Pharmacy(A) | $295K – $671K | Not stated | 46 |
| The Joint Chiropractic(A) | $245K – $543K | $570K | 970 |
| IV Nutrition(A) | $201K – $583K | $665K | 38 |
| MaxLiving(B) | $207K – $537K | $909K | 169 |
Each brand's own latest FDD. Item 19 averages are gross sales, not profit, and brands measure them differently.
Next steps before you buy a Good Neighbor Pharmacy franchise
3 steps
Read the FDD 14 days before you sign, call current and former owners, talk to an SBA lender and a franchise attorney.
The Good Neighbor Pharmacy FDD report · $19
- Every fee and Item 7 cost we read from the filing, by Item
- The 264 units that left in 2024, and the questions to ask about them
- Questions for your attorney, by Item
Full refund within 7 days if the data does not match the FDD. · sample
Compare before you decide
- Good Neighbor Pharmacy vs Prime IV Hydration & Wellness
- Good Neighbor Pharmacy vs 986 Pharmacy
- Good Neighbor Pharmacy vs The Joint Chiropractic
Already own a Good Neighbor Pharmacy? Benchmark your numbers against the filing
Steps and questions to ask
What to do next
Step 1: Read the FDD itself.
Free: the franchisor must give you its current FDD at least 14 days before you sign or pay. Or read the public copy in a state registry (Wisconsin, Minnesota, California). What to read first.
Step 2: Talk to current and former owners.
Free: Item 20 of the FDD lists every current owner and those who left last year, most with a phone number. Questions to ask.
Step 3: Talk to an SBA lender.
Free: the SBA's Lender Match, or the lenders already lending to this brand in the SBA section. Ask what you would personally guarantee and what the monthly payment would be. If you plan to use retirement savings, ask a CPA about the rules for that first.
Research steps, not investment or legal advice. Before you sign, have a franchise attorney review the FDD and the agreement: your state bar's lawyer referral service can name one, and many offer a short first consultation.
Good Neighbor Pharmacy franchise FAQ
7 answers
Cost, fees, earnings, closures, ownership, SBA loans and territory, each answered with the number first.
All questions
Frequently asked questions
How much does it cost to open a Good Neighbor Pharmacy franchise?
Per the 2025 FDD, the total investment to open a Good Neighbor Pharmacy franchise ranges from $279K to $575K. This is the Item 7 total in the Franchise Disclosure Document (FDD): the startup costs the franchisor lists, such as build-out, equipment, inventory and working capital. It usually leaves out buying land or a building; Item 7's notes say what is excluded.
What do Good Neighbor Pharmacy franchise owners earn?
Item 19 of the Good Neighbor Pharmacy FDD discloses figures for part of the system but no single average across all outlets. These are gross sales figures, not profit; the Revenue section shows what the filing reports and on what basis. Item 20 of the FDD lists current and former franchisees; asking them directly is the standard way to fill this gap.
Who owns Good Neighbor Pharmacy?
Good Neighbor Pharmacy is franchised by AmerisourceBergen Drug Corporation. Its parent company is Cencora, Inc.. Source: FDD Item 1, 2025 filing.
What is Item 19 in the Good Neighbor Pharmacy FDD?
The FDD section where a franchisor may disclose financial performance of its outlets. Disclosure is optional and formats vary; figures are typically gross sales, which is revenue before expenses, not profit. FranchiseVerdict extracts these figures directly from the Good Neighbor Pharmacy FDD and qualifies whose outlets they describe.
What is Good Neighbor Pharmacy's franchise failure rate?
There is no published franchise failure rate, and Good Neighbor Pharmacy has too few resolved SBA 7(a) loans on file (fewer than 10) to show an SBA charge-off rate that would mean anything. The SBA charge-off rate is the share of a brand's resolved SBA 7(a) loans to its franchisees that the SBA wrote off, including purchased guarantees. Resolved means paid in full or charged off; active loans are excluded because their outcome is not yet known. It is a lending outcome, not a count of closed businesses. Review the turnover and closure figures in Item 20 of the FDD and speak with current and former franchisees.
How many Good Neighbor Pharmacy franchise locations are there?
Per the 2025 FDD, Good Neighbor Pharmacy has 2,361 total units, including 2,204 franchised units and 0 company-owned units. In the latest year, the number of franchised outlets fell by 90 (174 opened, 264 closed).
Is Good Neighbor Pharmacy a good franchise to buy?
FranchiseVerdict gives Good Neighbor Pharmacy a B Verdict grade (Second tier) with a verdict score of 65 out of 100 (higher is better), an editorial assessment, not investment advice. Helped by financial health (audited financials), scale, legal record and transparency. Held back by unit growth (-94 franchised outlets over the two years to 2024: 2,298 to 2,204, -4.1% in total, -2.1% a year compounded). The “Why a B” section on this page lists all six dimensions and any adjustment. Speak with current franchisees before making any investment decision.
Sources
2025 FDD
Every FDD figure is read from the filing, with its page (3 of 3 headline figures cite one). Loans: SBA 7(a) records.
All sources and page cites
Source pages
- FDD 2025, Item 3, p. 17 Litigation
- FDD 2025, Item 3, p. 20 Lawsuits headline
- FDD 2025, Item 7, p. 26 Working capital
- FDD 2025, Item 7, p. 28 Total investment, Startup range
- FDD 2025, Item 15, p. 44 Owner-Operator
- FDD 2025, Item 20, p. 55 System size
Open a chip beside a figure for the line it reads. The filing itself is free in a state registry's public copy.
FDD issued: · Data extracted: · Last cited check: · Staleness risk: low (issued within the last 12 months)
Evidence for the headline figures: strong✓ Investment (Item 7)✓ Item 19 status✓ Units and owners (Item 20)✓ SBA loan coverage✓ Litigation (Item 3)✓ Financial statements (Item 21)✓ Franchisor identityhow this is scored3 of 3 headline figures on this page cite a page of the filing.
- [1]U.S. Small Business Administration: 7(a) loan-level disclosures released under the Freedom of Information Act. How the rate is computed: methodology.
- [2]Good Neighbor Pharmacy 2025 Franchise Disclosure Document, Items 5 (initial fees), 6 (recurring fees), 7 (initial investment), 19 (financial performance), 20 (unit counts and turnover), filed with state franchise regulators under FTC rule 16 CFR 436. Filed by AmerisourceBergen Drug Corporation. Read this filing.
How each headline figure is sourced
Verified: printed in the filing and restated elsewhere in it, or re-derived from the table's own arithmetic. Cited, not corroborated: printed on the page named, with nothing else in our record restating it. Not cited: published from our reading of the filing; the page has not been located.
- [3]How the verdict grade is built: methodology.
Recent checks against the filing (8)
- · Initial franchise fee · read from page 21 of the 2025 FDD
- · Franchise fee high · read from page 21 of the 2025 FDD
- · Franchise fee low · read from page 21 of the 2025 FDD
- · Ad fund · read from page 40 of the 2025 FDD
- · Ad fund rate text · read from page 40 of the 2025 FDD
- · Largest settlement amt · read from page 18 of the 2025 FDD
- · Total fee load pct · read from page 40 of the 2025 FDD
- · Total revenue · read from page 257 of the 2025 FDD
By the FranchiseVerdict editorial team · Reviewed against the 2025 FDD · Website ·
Cite this page
Citation
FranchiseVerdict. "Good Neighbor Pharmacy franchise profile." Source: 2025 Franchise Disclosure Document and SBA 7(a) loan data. Updated November 5, 2026. https://franchiseverdict.com/brand/good-neighbor-pharmacy
Link for a web page
<a href="https://franchiseverdict.com/brand/good-neighbor-pharmacy">Good Neighbor Pharmacy franchise profile (FranchiseVerdict)</a>
Free to quote with a link. Figures come from the filing or federal loan data named above; grades are FranchiseVerdict's editorial assessment, not investment advice. Press and data requests: press@franchiseverdict.com
This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.